Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
11.8M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
268K
-
Shares change
-
+127K
-
Total reported value, excl. options
-
$832K
-
Value change
-
+$410K
-
Number of buys
-
11
-
Number of sells
-
-2
-
Price
-
$3.10
Significant Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q3 2020
16 filings reported holding HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 268K shares
of 11.8M outstanding shares and own 2.28% of the company stock.
Largest 10 shareholders include BlackRock Inc. (60.6K shares), SABBY MANAGEMENT, LLC (57.3K shares), BANK OF AMERICA CORP /DE/ (33.2K shares), MILLENNIUM MANAGEMENT LLC (29.2K shares), CITADEL ADVISORS LLC (20.3K shares), GEODE CAPITAL MANAGEMENT, LLC (15.8K shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (15.6K shares), Squarepoint Ops LLC (15.5K shares), ExodusPoint Capital Management, LP (11.6K shares), and Tower Research Capital LLC (TRC) (4.52K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.